- Home
- NVO vs TD Comparison
NVO vs TD Comparison
Compare NVO & TD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | TD |
|---|---|---|
| Founded | 1923 | 1855 |
| Country | Denmark | Canada |
| Employees | 69500 | 102218 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.5B | 160.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | TD |
|---|---|---|
| Price | $38.45 | $96.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 1 |
| Target Price | $51.00 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 18.1M | 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 3.14% | ★ 3.15% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.30 | $4.22 |
| P/E Ratio | $13.60 | ★ $11.65 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.85 | $54.87 |
| 52 Week High | $81.44 | $99.84 |
Technical Indicators
Market Signals| Indicator | NVO | TD |
|---|---|---|
| Relative Strength Index (RSI) | 34.84 | 50.97 |
| Support Level | $35.85 | $93.09 |
| Resistance Level | $39.88 | $96.41 |
| Average True Range (ATR) | 0.89 | 1.80 |
| MACD | 0.48 | -0.31 |
| Stochastic Oscillator | 64.55 | 43.34 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TD Toronto Dominion Bank (The)
Toronto-Dominion is one of Canada's two largest banks with over CAD 2 trillion in assets. TD Bank operates four business segments: Canadian personal and commercial banking, US retail banking, wealth management and insurance, and wholesale banking. The bank derives more than 50% of its revenue from Canada and has dominant market share in nearly all banking products and services. TD has around 44% of its revenue from its US operations. Its US footprint spans from Maine to Florida, with a strong presence in the Northeast.